Aspira Womens Health Inc (AWH)
3.27
-0.13
(-3.82%)
USD |
NASDAQ |
Apr 25, 16:00
3.27
0.00 (0.00%)
After-Hours: 20:00
Aspira Womens Health Enterprise Value: 41.64M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 24, 2024 | 41.64M |
April 23, 2024 | 41.52M |
April 22, 2024 | 42.87M |
April 19, 2024 | 42.75M |
April 18, 2024 | 43.24M |
April 17, 2024 | 42.75M |
April 16, 2024 | 42.26M |
April 15, 2024 | 41.52M |
April 12, 2024 | 42.26M |
April 11, 2024 | 39.42M |
April 10, 2024 | 39.42M |
April 09, 2024 | 37.94M |
April 08, 2024 | 34.48M |
April 05, 2024 | 32.26M |
April 04, 2024 | 33.00M |
April 03, 2024 | 34.23M |
April 02, 2024 | 33.43M |
April 01, 2024 | 36.58M |
March 28, 2024 | 37.94M |
March 27, 2024 | 42.01M |
March 26, 2024 | 42.87M |
March 25, 2024 | 43.61M |
March 22, 2024 | 44.72M |
March 21, 2024 | 44.23M |
March 20, 2024 | 42.56M |
Date | Value |
---|---|
March 19, 2024 | 43.49M |
March 18, 2024 | 44.72M |
March 15, 2024 | 37.99M |
March 14, 2024 | 38.84M |
March 13, 2024 | 38.74M |
March 12, 2024 | 38.63M |
March 11, 2024 | 39.37M |
March 08, 2024 | 38.63M |
March 07, 2024 | 39.48M |
March 06, 2024 | 40.33M |
March 05, 2024 | 40.97M |
March 04, 2024 | 41.50M |
March 01, 2024 | 42.20M |
February 29, 2024 | 41.72M |
February 28, 2024 | 40.65M |
February 27, 2024 | 42.78M |
February 26, 2024 | 43.53M |
February 23, 2024 | 47.15M |
February 22, 2024 | 46.61M |
February 21, 2024 | 49.27M |
February 20, 2024 | 52.47M |
February 16, 2024 | 51.08M |
February 15, 2024 | 50.02M |
February 14, 2024 | 51.51M |
February 13, 2024 | 48.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
18.97M
Minimum
Jun 06 2023
1.007B
Maximum
Feb 11 2021
186.86M
Average
68.91M
Median
Enterprise Value Benchmarks
Bruker Corp | 12.15B |
Azenta Inc | 1.921B |
Harvard Bioscience Inc | 192.42M |
Bionano Genomics Inc | 14.52M |
Akoya Biosciences Inc | 179.36M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -3.089M |
Revenue (Quarterly) | 2.13M |
Total Expenses (Quarterly) | 6.265M |
EPS Diluted (Quarterly) | -0.27 |
Gross Profit Margin (Quarterly) | 57.23% |
Profit Margin (Quarterly) | -145.0% |
Earnings Yield | -53.82% |
Normalized Earnings Yield | -59.05 |